GREGORY DAVIDSON: Open Payments
NPI 1154809044 · MURRIETA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,306 in 123 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $232 · 2025 $2,306
Food & beverage: $2,136Education: $170
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 20 | $526 |
| Incyte Corporation | 19 | $233 |
| Arcutis Biotherapeutics, Inc. | 9 | $232 |
| Amgen Inc. | 14 | $205 |
| GENZYME CORPORATION | 7 | $179 |
| ABBVIE INC. | 13 | $173 |
| Janssen Biotech, Inc. | 6 | $163 |
| Galderma Laboratories, L.P. | 10 | $143 |
| LEO Pharma Inc. | 10 | $140 |
| Novartis Pharmaceuticals Corporation | 5 | $113 |
Products named: DUPIXENT, OPZELURA, Zoryve, OTEZLA, TREMFYA, NEMLUVIO, ADBRY, RINVOQ.
Industry payments across CA — which companies pay providers there.
